Our analysis demonstrated that BCR crosslinking on CLL cells with lower CD21 expression yielded significantly greater p-TYR response than if the BCR was cross linked on CLL cells with normal levels of CD21 (Figure 4a, 4b). This evidence concerns the gene CR2 and B-cell chronic lymphocytic leukemia.